Press release

Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2022-2023 Academic Year

- Recipients include 15 individuals living with Duchenne and five siblings in Duchenne families CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Sarepta

articleSarepta Therapeutics, Inc.September 7, 20225/company/sarepta-therapeutics-inc/news/sarepta-therapeutics-announces-recipients-of-route-79-the-duchenne-scholarship-2
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2022-2023 Academic Year

About this update from Sarepta Therapeutics, Inc.

[{"type":"text","content":"- Recipients include 15 individuals living with Duchenne and five siblings in Duchenne families CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced twenty recipients of Route 79, The Duchenne Scholarship Program for the 2022-2023 academic year. The Program was created in 2018 to recognize exceptional individuals living with Duchenne muscular dystrophy as they pursue their post-secondary education. Now in its fifth year, the Program was expanded to include siblings of individuals with Duchenne in recognition of the impact that a diagnosis of Duchenne may have on the entire family. Recipients of the scholarship are chosen by an independent selection committee composed of Duchenne community members, who consider each applicant’s community involvement and personal essay. Each student will receive a scholarship of up to $5,000. “On behalf of Sarepta and the selection committee, we are thrilled to announce the recipients of Route 79, The Duchenne Scholarship Program, for the 2022-2023 academic year. These twenty outstanding students are exemplary in their commitment and dedication to their studies. In addition to conveying their intellectual curiosity, the essays from this year’s recipients spoke to the power and strength of community and the importance of advocating for growth and change at a personal and societal level,” said Diane Berry, senior vice president, Global Health Policy, Government and Patient Affairs, Sarepta. “We are honored to support these young adults as they pursue their educational goals, and we wish them great success in the school year ahead and wherever their academic journey takes them.” 2022 Recipients – Individuals Living with DuchennePorter Aydelotte, California State University, Long BeachJared Conant, University of Southern MaineAiden Fecteau, Eastern Connecticut State UniversityBryson Foster, University of North Carolina, CharlotteYuvaraj Gambhir, University of PennsylvaniaMaanav Gupta, University of HoustonEthan Higginbotham, Wichita State UniversityElliott Johnson, Lebanon Valley CollegeJoshua Jurack, James Madison UniversityJohn McConnell, Boise State UniversityJosh Pflueger, Texas Christian UniversityRobert Sullivan, John Carroll UniversityTayjus Surampudi, Harvard UniversityJoseph W...

More updates from Sarepta Therapeutics, Inc.